-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FHN7Ze2+kSAvBPOHZDhE0PSqV6Ckq75vvcGlYvZLb7cl32fpjwmX+7lOtYEj18lu 5929UTqAbDcHkFy6bYlsSg== 0001127602-09-003657.txt : 20090213 0001127602-09-003657.hdr.sgml : 20090213 20090213191646 ACCESSION NUMBER: 0001127602-09-003657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090211 FILED AS OF DATE: 20090213 DATE AS OF CHANGE: 20090213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONGIORNO THOMAS F CENTRAL INDEX KEY: 0001222675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 09606323 BUSINESS ADDRESS: STREET 1: QUEST DIAGNOSTICS INC STREET 2: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 973-520-2187 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-02-11 0001022079 QUEST DIAGNOSTICS INC DGX 0001222675 BONGIORNO THOMAS F C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 VP and Corporate Controller Common Stock 2009-02-11 4 A 0 3226 0 A 9839 D Common Stock 2930 I 401k Common Stock 2200 I By Ira Stock Options (Right to Buy) 51.20 2009-02-11 4 A 0 10000 0 A 2019-02-11 Common Stock 10000 10000 D Represents an award of restricted share units granted February 11, 2009. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company stock as of that date. The options vest in three equal annual installments beginning on the first anniversary of the date of grant. The plan pursuant to which the stock options were granted has been amended, subject to approval of the Issuer's stockholders, to provide for a maximum option term of ten years from the grant date. If stockholders fail to approve the plan amendments at the 2009 annual meeting of stockholders, the term of the options reported on herein will revert to seven years (so that the expiration date will be 2/11/2016) in accordance with the terms of the plan prior to amendment. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Thomas F. Bongiorno 2009-02-13 -----END PRIVACY-ENHANCED MESSAGE-----